Uncategorized Archives - Radiation Nation

Adding Androgen Deprivation Therapy + Pelvic Nodal Radiation to Salvage Prostate Bed Radiation Therapy

June 16, 2022 Amy Le

The June 2022 #RadOnc #JC will focus on addition of ADT and pelvic lymph node radiation treatment to prostate bed salvage radiation. The June 18th-19th Journal Club will begin...

New ACGME Program Requirements

April 20, 2022 Amy Le

The April 2022 #RadOnc #JC focuses on recent changes to the ACGME Program Requirements for Graduate Medical Education (GME) in Radiation Oncology. The discussion will begin Saturday, April 23rd at 8...

High Dose, HyTEC – Guidance for Stereotactic and Hypofractionated Radiation Treatment Planning

June 10, 2021 Matthew Katz

Radiation oncology always seeks to strike the right balance between cancer control and the risk of treatment toxicity. As our understanding and technological abilities have evolved, so too has the...

Taking Cancer Research up a NOTCH

August 10, 2020 Matthew Katz

Usually, we discuss newly published cancer research for the journal club. Next weekend, we will discuss a new way for training physicians to organize and conduct research. What happens when...

Chemoradiation for Limited Stage Small Cell Lung Cancer: Are You CONVERTed?

September 10, 2017 Matthew Katz

For our September #radonc journal club we will discuss twice-daily versus daily chemoradiation for limited stage small cell lung cancer (LS-SCLC). Twice-daily radiation has been controversial for some time –...

Learning Leadership in Radiation Oncology: What is our Core Curriculum?

August 21, 2017 Matthew Katz

What are the key elements of leadership in radiation oncology? How do we teach it so that radiation oncologists can maintain a leading role in cancer care? Our article this...

Stereotactic Radiotherapy or Lobectomy for Stage I Non-Small Cell Lung Cancer?

December 14, 2015 Matthew Katz

Surgery is the current gold standard for operable clinical stage I non-small cell lung cancer, but stereotactic ablative radiotherapy (SABR) works well for medically inoperable patients. Is SABR safe to...

Chemoradiation De-Escalation in HPV+ Oropharyngeal Cancer: Exploring When Less is More

November 15, 2015 Matthew Katz

For the November journal club we will discuss a phase II trial of chemoradiation de-escalation for oropharyngeal cancer. Human papillomavirus (HPV)-related oropharyngeal cancers have a favorable prognosis – can we...

Cetuximab or Chemotherapy with Head & Neck Radiation

May 12, 2015 Miriam Knoll

Last month we discussed RTOG 0617, in which one of the randomization added cetuximab to standard chemotherapy for concurrent chemoradiation. The #RadOnc Journal Club 5/15-5/17 will discuss the use of cetuximab...

Uncategorized

11 articles

Stay up to date